Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol

被引：0
|
作者：
Buela, Gabriela [1 ]
Di Giuseppe, L. A. [1 ]
Zacariaz Hereter, J. B. [1 ]
Adrian Terrasa, Sergio [1 ]
Garfi, L. A. [1 ]
Soriano, E. R. [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
来源：
INTERNATIONAL JOURNAL OF INTEGRATED CARE | 2022年 / 22卷
关键词：
D O I：
10.5334/ijic.ICIC21151
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol
    Di Giuseppe, Luis A.
    Buela, Gabriela
    Zacariaz Hereter, Johana B.
    Terrasa, Sergio A.
    Garfi, Leonardo G.
    Soriano, Enrique R.
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2020, 21 : 201 - 204
  • [2] Risk-sharing agreement based on health outcomes for the treatment of moderatesevere psoriasis with certolizumab pegol
    Ruiz, Andres Navarro
    Alberola, Fernando Toledo
    Aceituno, Susana
    [J]. FARMACIA HOSPITALARIA, 2024, 48 (02) : 51 - 56
  • [3] Certolizumab pegol for the treatment of rheumatoid arthritis
    Horton, Sarah
    Walsh, Ceara
    Emery, Paul
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (02) : 235 - 249
  • [4] CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS: THE CANNOCK EXPERIENCE
    Roskell, Samantha
    Toms, Tracey
    Raghuvanshi, Subhra
    Price, Arthur
    Passey, Kathleen
    Sheeran, Thomas
    Venkatachalam, Srinivasan
    [J]. RHEUMATOLOGY, 2014, 53 : 111 - 111
  • [5] Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
    Connock, M.
    Tubeuf, S.
    Malottki, K.
    Uthman, A.
    Round, J.
    Bayliss, S.
    Meads, C.
    Moore, D.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 1 - 10
  • [6] Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland
    Soini, Erkki
    Asseburg, Christian
    Taiha, Maarit
    Puolakka, Kari
    Purcaru, Oana
    Luosujarvi, Riitta
    [J]. ADVANCES IN THERAPY, 2017, 34 (10) : 2316 - 2332
  • [7] Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland
    Erkki Soini
    Christian Asseburg
    Maarit Taiha
    Kari Puolakka
    Oana Purcaru
    Riitta Luosujärvi
    [J]. Advances in Therapy, 2017, 34 : 2316 - 2332
  • [8] Performance-based risk-sharing agreements in renal care: current experience and future prospects
    Drummond, Michael
    Federici, Carlo
    Busink, Ellen
    Apel, Christian
    Kendzia, Dana
    Brouwer, Werner
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (02) : 197 - 209
  • [9] Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
    Barnes, Theresa
    Moots, Robert
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (01) : 3 - 7
  • [10] Performance-Based Risk-Sharing Arrangements: An Updated International Review
    Carlson, Josh J.
    Chen, Shuxian
    Garrison, Louis P., Jr.
    [J]. PHARMACOECONOMICS, 2017, 35 (10) : 1063 - 1072
12345